Skip to content

    ADD & ADHD Health Center

    Font Size

    ADHD Drug Cylert Discontinued

    Company Cites Declining Sales for the Decision
    WebMD Health News

    March 25, 2005 -- Cylert, a stimulant drug for attention deficit hyperactivity disorder (ADHD), is being discontinued by its maker, Abbott Laboratories.

    Falling sales -- not safety questions -- are the reason, says Abbott spokeswoman Laureen Cassidy. "Cylert sales for this year will be less than $1 million," she tells WebMD. "It's been declining over the years."

    Cylert has been available since 1975. It's now available under its generic name, pemoline.

    The nonprofit group Public Citizen petitioned the FDA yesterday to remove Cylert -- including all generic versions of the drug -- citing an increased risk of serious liver problems and death from liver failure.

    The petition says that as of May 1996, Cylert had caused 13 cases of acute liver failure, resulting in death or liver transplantation in 11 cases. The petition also says that from 1975-1996, there were 193 "adverse drug reactions involving the liver in patients younger than 20 years old."

    Cassidy declined to comment on those charges, calling them unrelated to Cylert's discontinuation. Abbott had already decided to drop Cylert due to sales, she says.

    Abbott plans to give doctors several months to switch patients to other therapies, Cassidy adds.

    Today on WebMD

    Post it notes
    Symptoms and treatments.
    Close up of eye
    What's zapping your focus?
    man driving car
    How to manage your impulses.
    contemplating woman
    Learn to stop procrastinating.
    concentration killers
    Woman taking a vitamin or supplement
    ADHD and Substance Abuse
    Reduce Side Effects ADHD Medications

    woman with adhd doing college homework
    smiling man
    ADHD in Marriage and Romantic Relationships
    Adult man lying awake in bed